Literature DB >> 16673074

Transient splenium lesions in presurgical epilepsy patients: incidence and pathogenesis.

M Nelles1, C G Bien, M Kurthen, M von Falkenhausen, H Urbach.   

Abstract

INTRODUCTION: Transient splenium corporis callosi (SCC) lesions are related to rapid reduction of antiepileptic drugs (AEDs). The range of substances with predilection for SCC changes, their pathophysiology and their occurrence are still unknown.
METHODS: In a prospective 2-year study an epilepsy-dedicated MRI protocol supplemented by DWI and ADC maps was performed after AED withdrawal for diagnostic seizure provocation in all patients with pharmacoresistant seizures locally admitted to the Department of Epileptology.
RESULTS: Of 891 presurgical epilepsy patients, 6 (0.7%) had SCC lesions with cytotoxic edema on DWI. Carbamazepine combined with other AEDs was administered in five of those patients. In the study period we observed identical lesions in a schizophrenic patient treated with olanzapine and citalopram, in a patient with oropharyngeal carcinoma treated with alkylating agents, and in a hypernatremic patient following neurohypophyseal granular cell tumor surgery.
CONCLUSION: Transient SCC lesions are related to rapid AED reduction but may occur in similar conditions with fluid balance alterations. We contribute further clinical data in this field to better classify the pharmaceuticals that are prone to the described cerebral cytotoxic side effects in the SCC and to clarify their incidence among presurgical epilepsy patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673074     DOI: 10.1007/s00234-006-0080-5

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  34 in total

1.  Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study.

Authors:  Anna Gambini; Andrea Falini; Lucia Moiola; Giancarlo Comi; Giuseppe Scotti
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

2.  Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy.

Authors:  K K Tha; S Terae; M Sugiura; T Nishioka; M Oka; K Kudoh; K Kaneko; K Miyasaka
Journal:  Acta Neurol Scand       Date:  2002-12       Impact factor: 3.209

3.  Reversible abnormalities of DWI in high-altitude cerebral edema.

Authors:  S H Wong; N Turner; D Birchall; T J Walls; P English; M L Schmid
Journal:  Neurology       Date:  2004-01-27       Impact factor: 9.910

4.  Marchiafava-Bignami disease: reversibility of neuroimaging abnormality.

Authors:  A Gass; G Birtsch; M Olster; A Schwartz; M G Hennerici
Journal:  J Comput Assist Tomogr       Date:  1998 May-Jun       Impact factor: 1.826

5.  Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis.

Authors:  T Polster; M Hoppe; A Ebner
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

6.  Central nervous system involvement in a child with hemolytic uremic syndrome.

Authors:  E Signorini; S Lucchi; M Mastrangelo; S Rapuzzi; A Edefonti; E Fossali
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

7.  Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity?

Authors:  S S Kim; K H Chang; S T Kim; D C Suh; J E Cheon; S W Jeong; M H Han; S K Lee
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

8.  Corpus callosum lesions after closed head injury in children: MRI, clinical features and outcome.

Authors:  D B Mendelsohn; H S Levin; H Harward; D Bruce
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

9.  MR of cerebral malaria.

Authors:  Y S Cordoliani; J L Sarrazin; D Felten; E Caumes; C Lévêque; A Fisch
Journal:  AJNR Am J Neuroradiol       Date:  1998-05       Impact factor: 3.825

10.  Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy.

Authors:  H Ogura; M Takaoka; M Kishi; M Kimoto; T Shimazu; T Yoshioka; H Sugimoto
Journal:  AJNR Am J Neuroradiol       Date:  1998 Jun-Jul       Impact factor: 3.825

View more
  3 in total

1.  Reversible splenial abnormality in hypoglycemic encephalopathy.

Authors:  Ji Hyun Kim; Jeong Yoon Choi; Seong-Beom Koh; Younghen Lee
Journal:  Neuroradiology       Date:  2006-11-30       Impact factor: 2.804

2.  Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity.

Authors:  Shuo Zhang; Yan Ma; Juan Feng
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

Review 3.  Reversible lesion in the splenium of the corpus callosum.

Authors:  Syuichi Tetsuka
Journal:  Brain Behav       Date:  2019-10-06       Impact factor: 2.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.